Nanotechnology-Based Strategies against Antimicrobial Resistance: Current Status and Future Prospects

Pawan   Swami; Priya D.   Chouragade

doi:10.22270/jddt.v16i9.7988

Authors

Pawan Swami Faculty of Medical, Paramedical and Allied Health Sciences, Department of Pharmacy, Jagannath University, 303901, Jaipur, Rajasthan, India. https://orcid.org/0009-0006-2301-2460
Priya D. Chouragade Department of Quality Assurance, Imperial College of Pharmacy, Tiroda (DTE CODE-4750, MSBTE-32595), India. https://orcid.org/0009-0005-1279-2177

Abstract

Antimicrobial resistance (AMR) is a rapidly escalating global health crisis that threatens the effective treatment of infectious diseases. The emergence of multidrug-resistant (MDR) pathogens, coupled with the declining discovery of new antibiotics, has necessitated the development of innovative therapeutic strategies. Nanotechnology has emerged as a promising approach owing to its unique physicochemical properties, enabling targeted drug delivery, improved antimicrobial efficacy, enhanced biofilm penetration, and reduced systemic toxicity. This review aims to summarize recent advances in nanotechnology-based strategies for combating AMR, highlighting the mechanisms of action, therapeutic applications, current research progress, and future translational prospects. A comprehensive literature search was performed using PubMed, Scopus, Web of Science, and Google Scholar to identify relevant peer-reviewed articles published in recent years. Studies focusing on nanoparticle-based antimicrobial therapies, drug delivery systems, biofilm-targeting approaches, and clinical advancements were critically evaluated. Various nanoplatforms, including metallic, polymeric, lipid-based, and carbon-based nanoparticles, have demonstrated significant potential in overcoming conventional resistance mechanisms through targeted drug delivery, membrane disruption, reactive oxygen species generation, and controlled drug release. Additionally, nanotechnology enhances antibiotic stability, improves intracellular drug accumulation, and facilitates combination therapies. Despite promising preclinical outcomes, challenges related to toxicity, large-scale manufacturing, regulatory approval, and long-term safety remain barriers to clinical translation. Nanotechnology offers a transformative strategy to address antimicrobial resistance by improving therapeutic efficacy and minimizing resistance development. Continued interdisciplinary research, standardized safety evaluations, and well-designed clinical studies are essential to accelerate the successful clinical implementation of nano-enabled antimicrobial therapies.

Keywords: Antimicrobial resistance; Nanomedicine; Nanoparticle-based drug delivery; Biofilm inhibition; Precision antimicrobial therapy.

Keywords:

Antimicrobial resistance;, Nanomedicine, Nanoparticle-based drug delivery, Biofilm inhibition, Precision antimicrobial therapy

DOI

https://doi.org/10.22270/jddt.v16i9.7988

Author Biographies

Pawan Swami , Faculty of Medical, Paramedical and Allied Health Sciences, Department of Pharmacy, Jagannath University, 303901, Jaipur, Rajasthan, India.

Faculty of Medical, Paramedical and Allied Health Sciences, Department of Pharmacy, Jagannath University, 303901, Jaipur, Rajasthan, India.

Priya D. Chouragade , Department of Quality Assurance, Imperial College of Pharmacy, Tiroda (DTE CODE-4750, MSBTE-32595), India.

Department of Quality Assurance, Imperial College of Pharmacy, Tiroda (DTE CODE-4750, MSBTE-32595), India.

References

[1]. Mehrotra R., Cukor D., McCurry S.M., Rue T., Roumelioti M.-E., Heagerty P.J., Unruh M. Effectiveness of Existing Insomnia Therapies for Patients Undergoing Hemodialysis. Ann. Intern. Med. 2024;177:177–188. doi: 10.7326/M23-1794. [DOI] [PubMed] [Google Scholar]

[2]. Ahmed S.K., Hussein S., Qurbani K., Ibrahim R.H., Fareeq A., Mahmood K.A., Mohamed M.G. Antimicrobial Resistance: Impacts, Challenges, and Future Prospects. J. Med. Surg. Public Health. 2024;2:100081. doi: 10.1016/j.glmedi.2024.100081. [DOI] [Google Scholar]

[3]. Manyi-Loh C., Mamphweli S., Meyer E., Okoh A. Antibiotic Use in Agriculture and Its Consequential Resistance in Environmental Sources: Potential Public Health Implications. Molecules. 2018;23:795. doi: 10.3390/molecules23040795. [DOI] [PMC free article] [PubMed] [Google Scholar]

[4]. Jhalora V., Bist R. A Comprehensive Review of Molecular Mechanisms Leading to the Emergence of Multidrug Resistance in Bacteria. Indian J. Microbiol. 2024 doi: 10.1007/s12088-024-01384-6. [DOI] [Google Scholar]

[5]. Baciu A.-P., Baciu C., Baciu G., Gurau G. The Burden of Antibiotic Resistance of the Main Microorganisms Causing Infections in Humans—Review of the Literature. J. Med. Life. 2024;17:246–260. doi: 10.25122/jml-2023-0404. [DOI] [PMC free article] [PubMed] [Google Scholar]

[6]. Founou L.L., Founou R.C., Essack S.Y. Antimicrobial Resistance in the Farm-to-Plate Continuum: More Than a Food Safety Issue. Future Sci. OA. 2021;7:FSO692. doi: 10.2144/fsoa-2020-0189. [DOI] [PMC free article] [PubMed] [Google Scholar]

[7]. Talebi Bezmin Abadi A., Rizvanov A.A., Haertlé T., Blatt N.L. World Health Organization Report: Current Crisis of Antibiotic Resistance. Bionanoscience. 2019;9:778–788. doi: 10.1007/s12668-019-00658-4. [DOI] [Google Scholar]

[8]. Uddin T.M., Chakraborty A.J., Khusro A., Zidan B.R.M., Mitra S., Bin Emran T., Dhama K., Ripon M.K.H., Gajdács M., Sahibzada M.U.K., et al. Antibiotic Resistance in Microbes: History, Mechanisms, Therapeutic Strategies and Future Prospects. J. Infect. Public Health. 2021;14:1750–1766. doi: 10.1016/j.jiph.2021.10.020. [DOI] [PubMed] [Google Scholar]

[9]. Amábile-Cuevas C.F., Lund-Zaina S. Non-Canonical Aspects of Antibiotics and Antibiotic Resistance. Antibiotics. 2024;13:565. doi: 10.3390/antibiotics13060565. [DOI] [PMC free article] [PubMed] [Google Scholar]

[10]. Sharma S., Mohler J., Mahajan S.D., Schwartz S.A., Bruggemann L., Aalinkeel R. Microbial Biofilm: A Review on Formation, Infection, Antibiotic Resistance, Control Measures, and Innovative Treatment. Microorganisms. 2023;11:1614. doi: 10.3390/microorganisms11061614. [DOI] [PMC free article] [PubMed] [Google Scholar]

[11]. Uruén C., Chopo-Escuin G., Tommassen J., Mainar-Jaime R.C., Arenas J. Biofilms as Promoters of Bacterial Antibiotic Resistance and Tolerance. Antibiotics. 2020;10:3. doi: 10.3390/antibiotics10010003. [DOI] [PMC free article] [PubMed] [Google Scholar]

[12]. Muteeb G., Rehman M.T., Shahwan M., Aatif M. Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review. Pharmaceuticals. 2023;16:1615. doi: 10.3390/ph16111615. [DOI] [PMC free article] [PubMed] [Google Scholar]

[13]. Shim H. Three Innovations of Next-Generation Antibiotics: Evolvability, Specificity, and Non-Immunogenicity. Antibiotics. 2023;12:204. doi: 10.3390/antibiotics12020204. [DOI] [PMC free article] [PubMed] [Google Scholar]

[14]. Khan S., Hossain M.K. Nanoparticle-Based Polymer Composites. Elsevier; Amsterdam, The Netherlands: 2022. Classification and Properties of Nanoparticles; pp. 15–54. [Google Scholar]

[15]. Mammari N., Lamouroux E., Boudier A., Duval R.E. Current Knowledge on the Oxidative-Stress-Mediated Antimicrobial Properties of Metal-Based Nanoparticles. Microorganisms. 2022;10:437. doi: 10.3390/microorganisms10020437. [DOI] [PMC free article] [PubMed] [Google Scholar]

[16]. Malekkhaiat Häffner S., Malmsten M. Membrane Interactions and Antimicrobial Effects of Inorganic Nanoparticles. Adv. Colloid Interface Sci. 2017;248:105–128. doi: 10.1016/j.cis.2017.07.029. [DOI] [PubMed] [Google Scholar]

[17]. Shah TM. Exosomes next-generation approaches in breast cancer: nano drug delivery to AI-based prediction. J Drug Deliv Ther. 2026;16(7):239-253. doi:10.22270/jddt.v16i7.7891

[18]. Nazli A., He D.L., Liao D., Khan M.Z.I., Huang C., He Y. Strategies and Progresses for Enhancing Targeted Antibiotic Delivery. Adv. Drug Deliv. Rev. 2022;189:114502. doi: 10.1016/j.addr.2022.114502. [DOI] [PubMed] [Google Scholar]

[19]. León-Buitimea A., Garza-Cárdenas C.R., Román-García M.F., Ramírez-Díaz C.A., Ulloa-Ramírez M., Morones-Ramírez J.R. Nanomaterials-Based Combinatorial Therapy as a Strategy to Combat Antibiotic Resistance. Antibiotics. 2022;11:794. doi: 10.3390/antibiotics11060794. [DOI] [PMC free article] [PubMed] [Google Scholar]

[20]. Sadeghi S., Agharazi F., Hosseinzadeh S.A., Mashayekhi M., Saffari Z., Shafiei M., Shahrokhi N., Ebrahimi-Rad M., Sadeghi M. Gold Nanoparticle Conjugation Enhances Berberine’s Antibacterial Activity against Methicillin-Resistant Staphylococcus Aureus (MRSA) Talanta. 2024;268:125358. doi: 10.1016/j.talanta.2023.125358. [DOI] [PubMed] [Google Scholar]

[21]. Ahmed S.F., Mofijur M., Rafa N., Chowdhury A.T., Chowdhury S., Nahrin M., Islam A.B.M.S., Ong H.C. Green Approaches in Synthesising Nanomaterials for Environmental Nanobioremediation: Technological Advancements, Applications, Benefits and Challenges. Environ. Res. 2022;204:111967. doi: 10.1016/j.envres.2021.111967. [DOI] [PubMed] [Google Scholar]

[22]. Siwal S.S., Sheoran K., Mishra K., Kaur H., Saini A.K., Saini V., Vo D.-V.N., Nezhad H.Y., Thakur V.K. Novel Synthesis Methods and Applications of MXene-Based Nanomaterials (MBNs) for Hazardous Pollutants Degradation: Future Perspectives. Chemosphere. 2022;293:133542. doi: 10.1016/j.chemosphere.2022.133542. [DOI] [PubMed] [Google Scholar]

[23]. Kamble E., Sanghvi P., Pardesi K. Synergistic Effect of Antibiotic Combinations on Staphylococcus Aureus Biofilms and Their Persister Cell Populations. Biofilm. 2022;4:100068. doi: 10.1016/j.bioflm.2022.100068. [DOI] [PMC free article] [PubMed] [Google Scholar]

[24]. Coates A.R.M., Hu Y., Holt J., Yeh P. Antibiotic Combination Therapy against Resistant Bacterial Infections: Synergy, Rejuvenation and Resistance Reduction. Expert Rev. Anti-Infect. Ther. 2020;18:5–15. doi: 10.1080/14787210.2020.1705155. [DOI] [PubMed] [Google Scholar]

[25]. Cheesman M.J., Ilanko A., Blonk B., Cock I.E. Developing New Antimicrobial Therapies: Are Synergistic Combinations of Plant Extracts/Compounds with Conventional Antibiotics the Solution? Pharmacogn. Rev. 2017;11:57–72. doi: 10.4103/phrev.phrev_21_17. [DOI] [PMC free article] [PubMed] [Google Scholar]

[26]. Zhu Y., Hao W., Wang X., Ouyang J., Deng X., Yu H., Wang Y. Antimicrobial Peptides, Conventional Antibiotics, and Their Synergistic Utility for the Treatment of Drug-Resistant Infections. Med. Res. Rev. 2022;42:1377–1422. doi: 10.1002/med.21879. [DOI] [PubMed] [Google Scholar]

[27]. Pinto R.M., Soares F.A., Reis S., Nunes C., Van Dijck P. Innovative Strategies Toward the Disassembly of the EPS Matrix in Bacterial Biofilms. Front. Microbiol. 2020;11:952. doi: 10.3389/fmicb.2020.00952. [DOI] [PMC free article] [PubMed] [Google Scholar]

[28]. Bjarnsholt T., Whiteley M., Rumbaugh K.P., Stewart P.S., Jensen P.Ø., Frimodt-Møller N. The Importance of Understanding the Infectious Microenvironment. Lancet Infect. Dis. 2022;22:e88–e92. doi: 10.1016/S1473-3099(21)00122-5. [DOI] [PMC free article] [PubMed] [Google Scholar]

[29]. Huemer M., Mairpady Shambat S., Brugger S.D., Zinkernagel A.S. Antibiotic Resistance and Persistence—Implications for Human Health and Treatment Perspectives. EMBO Rep. 2020;21:e51034. doi: 10.15252/embr.202051034. [DOI] [PMC free article] [PubMed] [Google Scholar]

[30]. Ciofu O., Tolker-Nielsen T., Jensen P.Ø., Wang H., Høiby N. Antimicrobial Resistance, Respiratory Tract Infections and Role of Biofilms in Lung Infections in Cystic Fibrosis Patients. Adv. Drug Deliv. Rev. 2015;85:7–23. doi: 10.1016/j.addr.2014.11.017. [DOI] [PubMed] [Google Scholar]

[31]. Liu H.Y., Prentice E.L., Webber M.A. Mechanisms of Antimicrobial Resistance in Biofilms. npj Antimicrob. Resist. 2024;2:27. doi: 10.1038/s44259-024-00046-3. [DOI] [PMC free article] [PubMed] [Google Scholar]

[32]. Elston R., Mulligan C., Thomas G.H. Flipping the Switch: Dynamic Modulation of Membrane Transporter Activity in Bacteria. Microbiology. 2023;169:001412. doi: 10.1099/mic.0.001412. [DOI] [PMC free article] [PubMed] [Google Scholar]

[33]. Garcia Í.R., de Oliveira Garcia F.A., Pereira P.S., Coutinho H.D.M., Siyadatpanah A., Norouzi R., Wilairatana P., de Lourdes Pereira M., Nissapatorn V., Tintino S.R., et al. Microbial Resistance: The Role of Efflux Pump Superfamilies and Their Respective Substrates. Life Sci. 2022;295:120391. doi: 10.1016/j.lfs.2022.120391. [DOI] [PubMed] [Google Scholar]

[34]. Alenazy R. Drug Efflux Pump Inhibitors: A Promising Approach to Counter Multidrug Resistance in Gram-Negative Pathogens by Targeting AcrB Protein from AcrAB-TolC Multidrug Efflux Pump from Escherichia Coli. Biology. 2022;11:1328. doi: 10.3390/biology11091328. [DOI] [PMC free article] [PubMed] [Google Scholar]

[35]. Singh S., Datta S., Narayanan K.B., Rajnish K.N. Bacterial Exo-Polysaccharides in Biofilms: Role in Antimicrobial Resistance and Treatments. J. Genet. Eng. Biotechnol. 2021;19:140. doi: 10.1186/s43141-021-00242-y. [DOI] [PMC free article] [PubMed] [Google Scholar]

[36]. Avakh A., Grant G.D., Cheesman M.J., Kalkundri T., Hall S. The Art of War with Pseudomonas Aeruginosa: Targeting Mex Efflux Pumps Directly to Strategically Enhance Antipseudomonal Drug Efficacy. Antibiotics. 2023;12:1304. doi: 10.3390/antibiotics12081304. [DOI] [PMC free article] [PubMed] [Google Scholar]

[37]. Alfei S., Schito A.M. β-Lactam Antibiotics and β-Lactamase Enzymes Inhibitors, Part 2: Our Limited Resources. Pharmaceuticals. 2022;15:476. doi: 10.3390/ph15040476. [DOI] [PMC free article] [PubMed] [Google Scholar]

[38]. Shaikh S., Fatima J., Shakil S., Rizvi S.M.D., Kamal M.A. Antibiotic Resistance and Extended Spectrum Beta-Lactamases: Types, Epidemiology and Treatment. Saudi J. Biol. Sci. 2015;22:90–101. doi: 10.1016/j.sjbs.2014.08.002. [DOI] [PMC free article] [PubMed] [Google Scholar]

[39]. El-Khoury C., Mansour E., Yuliandra Y., Lai F., Hawkins B.A., Du J.J., Sundberg E.J., Sluis-Cremer N., Hibbs D.E., Groundwater P.W. The Role of Adjuvants in Overcoming Antibacterial Resistance Due to Enzymatic Drug Modification. RSC Med. Chem. 2022;13:1276–1299. doi: 10.1039/D2MD00263A. [DOI] [PMC free article] [PubMed] [Google Scholar]

[40]. Frost L.S., Leplae R., Summers A.O., Toussaint A. Mobile Genetic Elements: The Agents of Open Source Evolution. Nat. Rev. Microbiol. 2005;3:722–732. doi: 10.1038/nrmicro1235. [DOI] [PubMed] [Google Scholar]

[41]. Bilal M., Ashraf S.S., Barceló D., Iqbal H.M.N. Biocatalytic Degradation/Redefining “Removal” Fate of Pharmaceutically Active Compounds and Antibiotics in the Aquatic Environment. Sci. Total Environ. 2019;691:1190–1211. doi: 10.1016/j.scitotenv.2019.07.224. [DOI] [PubMed] [Google Scholar]

[42]. Hu X.-L., Shang Y., Yan K.-C., Sedgwick A.C., Gan H.-Q., Chen G.-R., He X.-P., James T.D., Chen D. Low-Dimensional Nanomaterials for Antibacterial Applications. J. Mater. Chem. B. 2021;9:3640–3661. doi: 10.1039/D1TB00033K. [DOI] [PubMed] [Google Scholar]

[43]. Pal, R., Ghosh, B., Dutta, P., Mukeshkumar Shah, T., & Singh, A. (2026). Cutting-edge nanonovel drug delivery carriers (NDCs) for tuberculosis (TB) management: insights into clinical trials and patent landscape. Journal of Microencapsulation, 1–31. https://doi.org/10.1080/02652048.2026.2684955

[44]. Dave P, Dudhat K. Quantum dots in breast cancer: emerging nanobiotechnological tools for targeted therapy and diagnosis. Analytical and Bioanalytical Electrochemistry. 2025 Sep 30;17(7):531-67.

[45]. Parvin N., Mandal T.K. Synthesis of a Highly Fluorescence Nitrogen-Doped Carbon Quantum Dots Bioimaging Probe and Its in Vivo Clearance and Printing Applications. RSC Adv. 2016;6:18134–18140. doi: 10.1039/C5RA25402G. [DOI] [Google Scholar]

[46]. Parvin N., Kumar V., Manikkavel A., Park S.-S., Kumar Mandal T., Woo Joo S. Great New Generation Carbon Microsphere-Based Composites: Facile Synthesis, Properties and Their Application in Piezo-Electric Energy Harvesting. Appl. Surf. Sci. 2023;613:156078. doi: 10.1016/j.apsusc.2022.156078. [DOI] [Google Scholar]

[47]. Roy A., Bulut O., Some S., Mandal A.K., Yilmaz M.D. Green Synthesis of Silver Nanoparticles: Biomolecule-Nanoparticle Organizations Targeting Antimicrobial Activity. RSC Adv. 2019;9:2673–2702. doi: 10.1039/C8RA08982E. [DOI] [PMC free article] [PubMed] [Google Scholar]

[48]. Jiang H.S., Zhang Y., Lu Z.W., Lebrun R., Gontero B., Li W. Interaction between Silver Nanoparticles and Two Dehydrogenases: Role of Thiol Groups. Small. 2019;15:e1900860. doi: 10.1002/smll.201900860. [DOI] [PubMed] [Google Scholar]

[49]. Al-Wrafy F.A., Al-Gheethi A.A., Ponnusamy S.K., Noman E.A., Fattah S.A. Nanoparticles Approach to Eradicate Bacterial Biofilm-Related Infections: A Critical Review. Chemosphere. 2022;288:132603. doi: 10.1016/j.chemosphere.2021.132603. [DOI] [PubMed] [Google Scholar]

[50]. Saifi M.A., Khan W., Godugu C. Cytotoxicity of Nanomaterials: Using Nanotoxicology to Address the Safety Concerns of Nanoparticles. Pharm. Nanotechnol. 2018;6:3–16. doi: 10.2174/2211738505666171023152928. [DOI] [PubMed] [Google Scholar]

[51]. Zou Y., Zhang Y., Yu Q., Chen H. Photothermal Bactericidal Surfaces: Killing Bacteria Using Light Instead of Biocides. Biomater. Sci. 2021;9:10–22. doi: 10.1039/D0BM00617C. [DOI] [PubMed] [Google Scholar]

[52]. Sirelkhatim A., Mahmud S., Seeni A., Kaus N.H.M., Ann L.C., Bakhori S.K.M., Hasan H., Mohamad D. Review on Zinc Oxide Nanoparticles: Antibacterial Activity and Toxicity Mechanism. Nano-Micro Lett. 2015;7:219–242. doi: 10.1007/s40820-015-0040-x. [DOI] [PMC free article] [PubMed] [Google Scholar]

[53]. Ma H., Brennan A., Diamond S.A. Photocatalytic Reactive Oxygen Species Production and Phototoxicity of Titanium Dioxide Nanoparticles Are Dependent on the Solar Ultraviolet Radiation Spectrum. Environ. Toxicol. Chem. 2012;31:2099–2107. doi: 10.1002/etc.1916. [DOI] [PubMed] [Google Scholar]

[54]. Raha S., Ahmaruzzaman M. ZnO Nanostructured Materials and Their Potential Applications: Progress, Challenges and Perspectives. Nanoscale Adv. 2022;4:1868–1925. doi: 10.1039/D1NA00880C. [DOI] [PMC free article] [PubMed] [Google Scholar]

[55]. Yong S.-S., Lee J.-I., Kang D.-H. TiO2-Based Photocatalyst Generated Reactive Oxygen Species Cause Cell Membrane Disruption of Staphylococcus Aureus and Escherichia Coli O157:H7. Food Microbiol. 2023;109:104119. doi: 10.1016/j.fm.2022.104119. [DOI] [PubMed] [Google Scholar]

[56]. Guan G., Zhang L., Zhu J., Wu H., Li W., Sun Q. Antibacterial Properties and Mechanism of Biopolymer-Based Films Functionalized by CuO/ZnO Nanoparticles against Escherichia Coli and Staphylococcus Aureus. J. Hazard. Mater. 2021;402:123542. doi: 10.1016/j.jhazmat.2020.123542. [DOI] [PubMed] [Google Scholar]

[57]. Mohammed H., Kumar A., Bekyarova E., Al-Hadeethi Y., Zhang X., Chen M., Ansari M.S., Cochis A., Rimondini L. Antimicrobial Mechanisms and Effectiveness of Graphene and Graphene-Functionalized Biomaterials. A Scope Review. Front. Bioeng. Biotechnol. 2020;8:465–486. doi: 10.3389/fbioe.2020.00465. [DOI] [PMC free article] [PubMed] [Google Scholar]

[58]. Parvin N., Kumar V., Joo S.W., Park S.-S., Mandal T.K. Recent Advances in the Characterized Identification of Mono-to-Multi-Layer Graphene and Its Biomedical Applications: A Review. Electronics. 2022;11:3345. doi: 10.3390/electronics11203345. [DOI] [Google Scholar]

[59]. Mandal T.K., Lee Y.R., Parvin N. Red Phosphorus Decorated Graphene Oxide Nanosheets: Label-Free DNA Detection. Biomater. Sci. 2020;8:125–131. doi: 10.1039/C9BM01341E. [DOI] [PubMed] [Google Scholar]

[60]. Karki N., Tiwari H., Tewari C., Rana A., Pandey N., Basak S., Sahoo N.G. Functionalized Graphene Oxide as a Vehicle for Targeted Drug Delivery and Bioimaging Applications. J. Mater. Chem. B. 2020;8:8116–8148. doi: 10.1039/D0TB01149E. [DOI] [PubMed] [Google Scholar]

[61]. Asaftei M., Lucidi M., Cirtoaje C., Holban A.-M., Charitidis C.A., Yang F., Wu A., Stanciu G.A., Sağlam Ö., Lazar V., et al. Fighting Bacterial Pathogens with Carbon Nanotubes: Focused Review of Recent Progress. RSC Adv. 2023;13:19682–19694. doi: 10.1039/D3RA01745A. [DOI] [PMC free article] [PubMed] [Google Scholar]

[62]. Cui F., Li T., Wang D., Yi S., Li J., Li X. Recent Advances in Carbon-Based Nanomaterials for Combating Bacterial Biofilm-Associated Infections. J. Hazard. Mater. 2022;431:128597. doi: 10.1016/j.jhazmat.2022.128597. [DOI] [PubMed] [Google Scholar]

[63]. Azizi-Lalabadi M., Hashemi H., Feng J., Jafari S.M. Carbon Nanomaterials against Pathogens; the Antimicrobial Activity of Carbon Nanotubes, Graphene/Graphene Oxide, Fullerenes, and Their Nanocomposites. Adv. Colloid Interface Sci. 2020;284:102250. doi: 10.1016/j.cis.2020.102250. [DOI] [PubMed] [Google Scholar]

[64]. Patel K.D., Keskin-Erdogan Z., Sawadkar P., Nik Sharifulden N.S.A., Shannon M.R., Patel M., Silva L.B., Patel R., Chau D.Y.S., Knowles J.C., et al. Oxidative Stress Modulating Nanomaterials and Their Biochemical Roles in Nanomedicine. Nanoscale Horiz. 2024;9:1630–1682. doi: 10.1039/D4NH00171K. [DOI] [PubMed] [Google Scholar]

[65]. Solano-Orrala D., Silva-Cullishpuma D.A., Díaz-Cruces E., Gómez-López V.M., Toro-Mendoza J., Gomez d’Ayala G., Troconis J., Narváez-Muñoz C., Alexis F., Mercader-Ros M.T., et al. Exploring the Potential of Nonpsychoactive Cannabinoids in the Development of Materials for Biomedical and Sports Applications. ACS Appl. Bio Mater. 2024;7:8177–8202. doi: 10.1021/acsabm.4c01402. [DOI] [PubMed] [Google Scholar]

[66]. Sivaram A.J., Rajitha P., Maya S., Jayakumar R., Sabitha M. Nanogels for Delivery, Imaging and Therapy. WIREs Nanomed. Nanobiotechnol. 2015;7:509–533. doi: 10.1002/wnan.1328. [DOI] [PubMed] [Google Scholar]

[67]. Keskin D., Zu G., Forson A.M., Tromp L., Sjollema J., van Rijn P. Nanogels: A Novel Approach in Antimicrobial Delivery Systems and Antimicrobial Coatings. Bioact. Mater. 2021;6:3634–3657. doi: 10.1016/j.bioactmat.2021.03.004. [DOI] [PMC free article] [PubMed] [Google Scholar]

[68]. Ali A.A., Al Bostami R.D., Al-Othman A. Nanogel-Based Composites for Bacterial Antibiofilm Activity: Advances, Challenges, and Prospects. RSC Adv. 2024;14:10546–10559. doi: 10.1039/D4RA00410H. [DOI] [PMC free article] [PubMed] [Google Scholar]

[69]. He J., Hong M., Xie W., Chen Z., Chen D., Xie S. Progress and Prospects of Nanomaterials against Resistant Bacteria. J. Control. Release. 2022;351:301–323. doi: 10.1016/j.jconrel.2022.09.030. [DOI] [PubMed] [Google Scholar]

[70]. Jangid H., Singh S., Kashyap P., Singh A., Kumar G. Advancing Biomedical Applications: An in-Depth Analysis of Silver Nanoparticles in Antimicrobial, Anticancer, and Wound Healing Roles. Front. Pharmacol. 2024;15:1438227. doi: 10.3389/fphar.2024.1438227. [DOI] [PMC free article] [PubMed] [Google Scholar]